XML 30 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of fair values of stock options granted, estimated using Black-Scholes option valuation model assumptions
We estimated the fair value of stock options awarded during the six months ended June 30, 2017 and 2018 using the Black-Scholes option valuation model. The fair values of stock options granted for the periods were estimated using the following assumptions: 
 
Stock Option Grants Awarded During the Six Months Ended June 30, 2017
 
Stock Option Grants Awarded During the Six Months Ended June 30, 2018
Stock Price
$4.36 to $4.68
 
$4.12 to $5.96
Dividend Yield
0.00%
 
0.00%
Expected Volatility
60%
 
70%
Risk-free interest rate
1.98% - 2.14%
 
2.50% - 2.89%
Expected Life
7 years
 
7 years
Summary of stock option activity
The following is a summary of our stock option activity during the six months ended June 30, 2018
 
Number of
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Grant Date
Fair Value
 
Weighted
Average
Remaining
Life In
Years
Outstanding, January 1, 2018
1,082,490

 
$
4.87

 
$
3.00

 
8.38
Granted
117,500

 
4.93

 
3.34

 
9.00
Exercised
(4,692
)
 
2.91

 
1.75

 
Canceled / Forfeited
(65,645
)
 
4.72

 
2.89

 
Outstanding, June 30, 2018
1,129,653

 
$
4.89

 
$
3.05

 
8.02

 
 
Number of
Options
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Grant Date
Fair Value
 
Weighted
Average
Remaining
Life In
Years
Exercisable, January 1, 2018
704,303

 
$
5.08

 
$
3.17

 
8.15
Vested
74,002

 
4.76

 
2.89

 
7.69
Exercised
(4,692
)
 
2.91

 
1.75

 
Canceled / Forfeited
(16,432
)
 
4.69

 
2.80

 
Exercisable, June 30, 2018
757,181

 
$
5.07

 
$
3.16

 
7.66
Schedule of information related to stock options outstanding and exercisable
The following table presents information related to stock options outstanding and exercisable at June 30, 2018
Options Outstanding
 
Options Exercisable
Exercise
Price
 
Outstanding
Number of
Options
 
Weighted
Average
Remaining
Life In
Years
 
Exercisable
Number
of Options
$1.93 – $2.00
 
146,183

 
7.60
 
81,009

$3.83 – $4.75
 
556,045

 
8.90
 
355,058

$5.01 – $6.00
 
267,125

 
6.21
 
202,358

$6.18 – $7.20
 
70,000

 
6.34
 
49,697

$7.54 – $7.80
 
67,800

 
6.54
 
50,299

$8.06 – $12.98
 
22,500

 
6.55
 
18,760

 
 
1,129,653

 
7.66
 
757,181

Schedule of restricted stock unit activity
A summary of restricted stock unit activity for the six months ended June 30, 2018 is as follows: 
 
Number of
Restricted Share
Units
 
Weighted-
Average
Grant-Date Fair
Value Per Share
Outstanding at January 1, 2018
1,476,858

 
$
4.96

Granted
1,171,304

 
4.76

Vested
(478,816
)
 
5.01

Forfeited
(6,799
)
 
4.98

Outstanding at June 30, 2018
2,162,547

 
$
4.84

Schedule of stock-based compensation
Total equity-based compensation costs recorded in the condensed consolidated statements of operations is allocated as follows: 
 
 
Three Months Ended June 30, 2017
 
Three Months Ended June 30, 2018
 
Six Months Ended June 30, 2017
 
Six Months Ended June 30, 2018
Research and development
 
 
 
 
 
 
 
 
Employees
 
$
309,000

 
$
767,000

 
$
535,000

 
$
1,303,000

Non-employees
 
15,000

 
49,000

 
41,000

 
44,000

Total research and development
 
324,000

 
816,000

 
576,000

 
1,347,000

 
 
 
 
 
 
 
 
 
General and administrative
 
 
 
 
 
 
 
 
Employees and directors
 
317,000

 
727,000

 
684,000

 
1,134,000

Non-employees
 
24,000

 
84,000

 
98,000

 
109,000

Total general and administrative
 
341,000

 
811,000

 
782,000

 
1,243,000

 
 
 
 
 
 
 
 
 
Total equity-based compensation
 
$
665,000

 
$
1,627,000

 
$
1,358,000

 
$
2,590,000